Erlocip 150mg Tablet

$9,502.00 $6,176.00 Save $3,326 · 35%

Composition: Erlotinib Manufacturer/Trademark: Cipla

Genuine Stock

Export Docs

Discreet Pack

Qty:

Prescription Medicine This product requires a valid prescription. Please consult your physician before use and follow their guidance on dosage and administration.

Erlocip 150mg Tablet contains Erlotinib, a potent oral tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR). This medication is primarily indicated for the treatment of advanced non-small cell lung cancer (NSCLC) and pancreatic cancer. By blocking EGFR signaling, Erlotinib helps to impede tumor growth and spread, making it a crucial component of targeted cancer therapy.

Key Features:

Contains Erlotinib, a leading oral targeted therapy
Used for treating non-small cell lung cancer (NSCLC) and pancreatic cancer
Inhibits the action of EGFR to slow down cancer cell growth
Convenient oral administration for easy patient compliance
Often used as part of a comprehensive cancer treatment regimen

Orders ship from our India Head Office within 1–2 business days of confirmation. We include full customs documentation — HS codes, certificates of origin, and pharmaceutical export permits.

Estimated delivery: 3–7 business days to UK. 7–10 business days to UAE, Saudi Arabia and Gulf countries. 10–15 days for USA and Asian countries.

All packages arrive in plain, unmarked brown boxes. No pharmacy name or medication details on the outside.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Erlocip 150mg Tablet

Reviews

Health Tips & Exclusive Offers